Cholestatic syndrome in viral hepatitis A. 2012

Andrey I Petrov, and Nikolay T Vatev, and Maria V Atanasova
Department of Lnfectious Diseases, Parasitology and Tropical Medicine, St. George University Hospital, Medical University, Plovdiv, Bulgaria. dr_andre_petrov@yahoo.com

OBJECTIVE To study the cholestatic forms of viral hepatitis A that are described as unusual and very rare, but that are of great significance because of their severe course and high morbidity rate. METHODS We describe herein 17 cases of hepatitis A virus (HAV) infection with pronounced cholestasis treated in the Clinic of Infectious Diseases at St. George University Hospital between 2002 and 2006. They are taken from a contingent of 820 patients we studied in the course of the research: of these 400 were cases of sporadic disease and 420 patients were involved in an epidemic outbreak of the disease. All got this diagnosis based on an anti-HAV/IgM test. Eight parameters were analyzed: age, max TBil, max ALT, ALP, GGT, no urobilinogen in urine, ultrasound monitoring of hepatomegaly, and hospital stay. RESULTS The 17 patients we discuss here are 2.07% of the total 820 patients with viral hepatitis A (VHA). In 14 the disease had a cholestatic component; 3 cases were a cholestatic form of the disease. The mean hospital stay was 49.1 +/- 11.5 days, the longest--75 days. The hyperbilirubinemia had high levels at the disease climax - the mean concentration was 356.6 microkmol/l, and remained greater than 150 microkmol/l for more than a month. In 10 patients (58.2%) transaminase activity was over 1400 U/l, (mean 2011 U/l). CONCLUSIONS Viral hepatitis A ran with cholestatic syndrome in 2.07%; 23.5% of these cases were classified as severe forms of the disease and 76.5%--as moderate. This is evinced by the enhanced transaminase activity, the elevated TBil, pronounced intoxication, the adynamia, vomiting, headache, the vertigo, all of these items in the objective severity score system we used.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D005260 Female Females
D006506 Hepatitis A INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water. Hepatitis, Infectious,Infectious Hepatitis,Hepatitides, Infectious,Infectious Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin

Related Publications

Andrey I Petrov, and Nikolay T Vatev, and Maria V Atanasova
March 1982, MMW, Munchener medizinische Wochenschrift,
Andrey I Petrov, and Nikolay T Vatev, and Maria V Atanasova
January 1987, Pediatriia,
Andrey I Petrov, and Nikolay T Vatev, and Maria V Atanasova
January 1962, Polskie Archiwum Medycyny Wewnetrznej,
Andrey I Petrov, and Nikolay T Vatev, and Maria V Atanasova
January 1965, Medicinski glasnik,
Andrey I Petrov, and Nikolay T Vatev, and Maria V Atanasova
January 1988, Sovetskaia meditsina,
Andrey I Petrov, and Nikolay T Vatev, and Maria V Atanasova
February 1973, La Nouvelle presse medicale,
Andrey I Petrov, and Nikolay T Vatev, and Maria V Atanasova
March 1991, Anales espanoles de pediatria,
Andrey I Petrov, and Nikolay T Vatev, and Maria V Atanasova
July 1979, Pediatriia,
Andrey I Petrov, and Nikolay T Vatev, and Maria V Atanasova
August 1974, Clinical pediatrics,
Andrey I Petrov, and Nikolay T Vatev, and Maria V Atanasova
February 1993, Zeitschrift fur Gastroenterologie,
Copied contents to your clipboard!